| 36895677 | Lessons learned from the implementation of integrated serosurveillance of communicable diseases in the Americas. | Rev Panam Salud Publica | 2023 |
| 37736039 | Characterizing infection of B cells with wild-type and vaccine strains of measles virus. | iScience | 2023 |
| 36992247 | Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children? | Vaccines (Basel) | 2023 |
| 37262007 | Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022. | MMWR Morb Mortal Wkly Rep | 2023 |
| 34802478 | Descriptive evaluation of antibody responses to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in plasma and gingival crevicular fluid in a nursing home cohort-Arkansas, June-August 2020. | Infect Control Hosp Epidemiol | 2022 |
| 35895418 | Performance of SARS-CoV-2 Antigens in a Multiplex Bead Assay for Integrated Serological Surveillance of Neglected Tropical and Other Diseases. | Am J Trop Med Hyg | 2022 |
| 33395380 | Rapid Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Detention Facility, Louisiana, USA, May-June, 2020. | Emerg Infect Dis | 2021 |
| 33731416 | Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population Immunity. | J Clin Microbiol | 2021 |
| 33693830 | Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States. | J Infect Dis | 2021 |
| 33723510 | Infectious Period of Severe Acute Respiratory Syndrome Coronavirus 2 in 17 Nursing Home Residents-Arkansas, June-August 2020. | Open Forum Infect Dis | 2021 |
| 32881855 | Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020. | MMWR Morb Mortal Wkly Rep | 2020 |
| 33237893 | Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020. | MMWR Morb Mortal Wkly Rep | 2020 |
| 32940635 | Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee. | JAMA | 2020 |
| 28982603 | In vitro infectivity of oncolytic Newcastle Disease Virus: Correlation between plaque and fluorescent focus assays. | J Virol Methods | 2018 |
| 29456016 | Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine. | Vaccine | 2018 |
| 28106841 | Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies. | Viruses | 2017 |
| 26192359 | Effect of jet injection on infectivity of measles, mumps, and rubella vaccine in a bench model. | Vaccine | 2015 |
| 23280948 | Contribution of dendritic cells to measles virus induced immunosuppression. | Rev Med Virol | 2013 |
| 21905149 | Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential. | Rev Med Virol | 2012 |
| 23185609 | Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing. | PLoS One | 2012 |
| 21787825 | Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine. | Vaccine | 2011 |
| 19748648 | Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms. | Virology | 2009 |
| 19645480 | Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease. | J Med Chem | 2009 |
| 18796354 | Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors. | Bioorg Med Chem Lett | 2008 |
| 18852458 | A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. | Proc Natl Acad Sci U S A | 2008 |
| 17161858 | Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse. | Virology | 2007 |
| 16864705 | Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. | Pediatr Res | 2006 |
| 16849509 | The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. | J Immunol | 2006 |